Effects of mistletoe products on pharmacokinetic drug turnover by inhibition and induction of cytochrome P450 activities
Abstract Background European mistletoe (Viscum album) products used in cancer therapy are frequently combined with other anti-cancer-drugs. Hence, potential herb-drug interactions have become a major safety concern in mistletoe therapy. Methods Three European mistletoe products (Helixor® A, Helixor®...
Saved in:
Main Authors: | Michael Schink (Author), Oliver Dehus (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2017-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmakokinetics of Mistletoe Lectins after Intravenous Application of a Mistletoe Product in Healthy Subjects
by: Ann-Kathrin Lederer, et al.
Published: (2024) -
Applying Physiologically Based Pharmacokinetic Modeling to Interpret Carbamazepine's Nonlinear Pharmacokinetics and Its Induction Potential on Cytochrome P450 3A4 and Cytochrome P450 2C9 Enzymes
by: Xuefen Yin, et al.
Published: (2024) -
Succinic acid inhibits the activity of cytochrome P450 (CYP450) enzymes
by: Hao Wang, et al.
Published: (2020) -
Inhibition of Human Cytochrome P450 Metabolism by Blended Herbal Products and Vitamins
by: Teresa W Tam, et al.
Published: (2011) -
Inhibition and Induction by Poziotinib of Different Rat Cytochrome P450 Enzymes In Vivo and in an In Vitro Cocktail Method
by: Jinhui Wang, et al.
Published: (2021)